Valneva SE (VALN) Net Margin (2021 - 2026)
Valneva SE (VALN) posted quarterly Net Margin of 76.68% for Q1 2026, down 6457.0% year-on-year from 1.21% in Q1 2025, and up 41.05% on a QoQ basis from 130.08% in Q4 2025.
Valneva SE (VALN) Net Margin (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported Net Margin for 6 consecutive years, with 76.68% the latest figure, recorded in Q1 2026.
- Quarterly Net Margin fell 6457.0% year-over-year to 76.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 95.3% (down 6146.0% YoY) and the FY2025 annual result came in at 72.97%, down 8113.0% from the prior year.
- Net Margin rose to 76.68% in Q1 2026 per VALN's latest filing, from 130.08% in the prior quarter.
- Over the last five years, Net Margin for VALN reached as high as 208.25% in Q1 2024 and fell as low as 221.49% in Q3 2025.
- A 5-year average of 53.16% and a median of 52.69% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin surged 76476 bps — and 2025, when it tumbled 22036 bps.
- Year by year, Net Margin stood at 50.58% in 2022, then fell by 18 bps to 59.45% in 2023, then soared by 62 bps to 22.38% in 2024, then slumped by 481 bps to 130.08% in 2025, then surged by 41 bps to 76.68% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 76.68%, 130.08%, and 221.49% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -76.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.68% |
| Dec 31, 2025 | -130.08% |
| Sep 30, 2025 | -221.49% |
| Jun 30, 2025 | -22.49% |
| Mar 31, 2025 | -12.11% |
| Dec 31, 2024 | -22.38% |
| Sep 30, 2024 | -52.69% |
| Jun 30, 2024 | -56.61% |
| Mar 31, 2024 | 208.25% |
| Dec 31, 2023 | -59.45% |
| Sep 30, 2023 | -58.35% |
| Jun 30, 2023 | -45.71% |
| Mar 31, 2023 | -49.46% |
| Dec 31, 2022 | -50.58% |
| Sep 30, 2022 | 59.56% |
| Jun 30, 2022 | -198.82% |
| Mar 31, 2022 | -114.60% |
| Dec 31, 2021 | 60.82% |
| Sep 30, 2021 | -705.20% |
| Jun 30, 2021 | -233.15% |